About Guillermo Morales
Form D filings for SignalRX Pharmaceuticals in 2023 list Guillermo Morales as director.
Guillermo Morales first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Guillermo Morales in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Guillermo Morales works with at each company, as listed on that company's latest Form D.
SignalRX Pharmaceuticals, Inc · Form D, May 3, 2023
JW
Joel Wernick
Director
MW
Matthew Williams
Director and Chief Executive Officer